LOPERAMIDE HCL

LOPERAMIDE HCL was reported 13003 times

LOPERAMIDE HCL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 106 0.3498
1 PRESBYACUSIS 57 0.1851
2 HEART SOUNDS 15 0.1562
3 TOTAL LUNG CAPACITY INCREASED 30 0.1103
4 GENITOURINARY TRACT NEOPLASM 9 0.1084
5 STOMATITIS HAEMORRHAGIC 11 0.0902
6 FEMALE GENITAL TRACT FISTULA 113 0.0661
7 PLEURAL THICKENING 45 0.0658
8 STOMA SITE ULCER 11 0.0621
9 PLEURAL FIBROSIS 59 0.0579
10 BLOOD MAGNESIUM INCREASED 52 0.0576
11 PROLONGED EXPIRATION 15 0.0573
12 ANTICHOLINERGIC SYNDROME 75 0.0471
13 METASTASES TO SPINAL CORD 9 0.0464
14 GASTROINTESTINAL STOMA OUTPUT INCREASED 20 0.0426
15 RADICULOPATHY 106 0.0402
16 PROCTITIS 112 0.0399
17 CHRONIC SINUSITIS 148 0.0394
18 ARRHYTHMIC STORM 9 0.0269
19 PELVIC NEOPLASM 9 0.0260
20 GASTROENTERITIS RADIATION 8 0.0244
21 MACULAR DEGENERATION 272 0.0228
22 BONE CYST 21 0.0224
23 METASTASES TO ABDOMINAL CAVITY 11 0.0224
24 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 11 0.0219
25 HEMIANOPIA 21 0.0212
26 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 11 0.0210
27 TUMOUR PAIN 27 0.0205
28 INCORRECT PRODUCT ADMINISTRATION DURATION 444 0.0205
29 STICKY SKIN 8 0.0201
30 DEAFNESS NEUROSENSORY 59 0.0179
31 CREATININE RENAL CLEARANCE ABNORMAL 8 0.0173
32 VANISHING BILE DUCT SYNDROME 18 0.0161
33 EPIGASTRIC DISCOMFORT 62 0.0159
34 TORSADE DE POINTES 118 0.0150
35 ACQUIRED HAEMOPHILIA 15 0.0150
36 SALPINGECTOMY 8 0.0139
37 OSTEOSCLEROSIS 21 0.0133
38 NIPPLE DISORDER 8 0.0129
39 EXPOSURE TO TOXIC AGENT 36 0.0112
40 CHOROIDAL EFFUSION 9 0.0112
41 GASTROINTESTINAL STOMA COMPLICATION 17 0.0108
42 GASTRIC PH DECREASED 11 0.0107
43 BRUGADA SYNDROME 11 0.0106
44 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 54 0.0105
45 VAGINAL DISCHARGE 106 0.0105
46 ENTEROCUTANEOUS FISTULA 9 0.0102
47 PRODUCT INEFFECTIVE 8 0.0102
48 INTENTIONAL PRODUCT USE ISSUE 872 0.0099
49 WAIST CIRCUMFERENCE INCREASED 10 0.0096
50 PARAESTHESIA ORAL 137 0.0095
51 ORAL CANDIDIASIS 125 0.0095
52 VASCULAR DEVICE INFECTION 43 0.0095
53 OOPHORECTOMY 8 0.0090
54 MEGACOLON 14 0.0089
55 CONDUCTION DISORDER 15 0.0082
56 FORCED EXPIRATORY VOLUME DECREASED 23 0.0081
57 CATHETER RELATED INFECTION 8 0.0079
58 VENTRICULAR TACHYCARDIA 129 0.0078
59 NEUTROPHIL COUNT ABNORMAL 22 0.0078
60 RHEUMATOID FACTOR INCREASED 8 0.0072
61 EXPIRED PRODUCT ADMINISTERED 237 0.0071
62 IMMUNE-MEDIATED ENTEROCOLITIS 26 0.0071
63 INCORRECT DRUG ADMINISTRATION DURATION 193 0.0069
64 CLOSTRIDIUM COLITIS 8 0.0066
65 ENTEROCOLITIS 38 0.0066
66 FREQUENT BOWEL MOVEMENTS 170 0.0063
67 LONG QT SYNDROME 15 0.0063
68 COLON CANCER METASTATIC 10 0.0062
69 RESPIRATION ABNORMAL 41 0.0059
70 ACCIDENTAL POISONING 8 0.0058
71 CARDIOTOXICITY 51 0.0057
72 ANAL HAEMORRHAGE 16 0.0057
73 PYELONEPHRITIS ACUTE 11 0.0056
74 THERAPEUTIC PRODUCT EFFECT DELAYED 25 0.0055
75 CANCER PAIN 14 0.0055
76 VENTRICULAR ARRHYTHMIA 20 0.0055
77 VENA CAVA THROMBOSIS 9 0.0054
78 SMALL INTESTINAL OBSTRUCTION 66 0.0054
79 SMALL INTESTINAL PERFORATION 10 0.0053
80 COLITIS MICROSCOPIC 25 0.0053
81 ELECTROCARDIOGRAM QT PROLONGED 187 0.0052
82 COLITIS 197 0.0052
83 HEPATIC NEOPLASM MALIGNANT 11 0.0052
84 PROCEDURAL PAIN 144 0.0052
85 CYST 64 0.0052
86 JAUNDICE CHOLESTATIC 18 0.0051
87 ILEUS PARALYTIC 22 0.0049
88 ATRIOVENTRICULAR BLOCK FIRST DEGREE 21 0.0048
89 PEPTIC ULCER 16 0.0048
90 RHINITIS ALLERGIC 21 0.0047
91 MUSCULOSKELETAL CHEST PAIN 73 0.0047
92 APPETITE DISORDER 31 0.0047
93 BLOOD AMYLASE INCREASED 8 0.0047
94 THERAPEUTIC PRODUCT EFFECT VARIABLE 18 0.0046
95 HYPOMANIA 17 0.0046
96 PRODUCT PACKAGING DIFFICULT TO OPEN 12 0.0046
97 FANCONI SYNDROME ACQUIRED 8 0.0046
98 DEPRESSIVE SYMPTOM 16 0.0045
99 FOREIGN BODY IN THROAT 14 0.0044
100 ESSENTIAL HYPERTENSION 8 0.0044
101 SOFT TISSUE INFECTION 8 0.0044
102 OSTEOPENIA 66 0.0043
103 HYPOMAGNESAEMIA 60 0.0043
104 BLOOD BICARBONATE DECREASED 8 0.0042
105 FAECES DISCOLOURED 91 0.0042
106 DRUG EFFECT DELAYED 19 0.0042
107 INTRACRANIAL PRESSURE INCREASED 23 0.0041
108 FAECES HARD 16 0.0041
109 PNEUMONIA VIRAL 13 0.0041
110 LEFT VENTRICULAR FAILURE 14 0.0041
111 CHOLANGITIS 25 0.0040
112 PORTAL VEIN THROMBOSIS 13 0.0040
113 FAECALOMA 22 0.0040
114 BLOOD POTASSIUM INCREASED 65 0.0040
115 DECREASED IMMUNE RESPONSIVENESS 39 0.0040
116 RALES 23 0.0040
117 ELECTROLYTE IMBALANCE 46 0.0040
118 ABNORMAL FAECES 32 0.0039
119 PYODERMA GANGRENOSUM 14 0.0039
120 PROCTALGIA 25 0.0039
121 VENTRICULAR FIBRILLATION 43 0.0039
122 HYPOALBUMINAEMIA 30 0.0039
123 HYPOKALAEMIA 178 0.0039
124 DERMATITIS EXFOLIATIVE GENERALISED 13 0.0037
125 ORAL INTAKE REDUCED 9 0.0037
126 LUNG ADENOCARCINOMA 11 0.0037
127 LARGE INTESTINE PERFORATION 25 0.0036
128 ENTERITIS 23 0.0036
129 HYPOPHOSPHATAEMIA 26 0.0035
130 RECTAL HAEMORRHAGE 151 0.0035
131 BRONCHOPNEUMONIA 12 0.0035
132 ARTERIOSPASM CORONARY 14 0.0035
133 MALNUTRITION 39 0.0035
134 GASTROINTESTINAL PAIN 38 0.0035
135 HAEMATOCHEZIA 190 0.0034
136 FAECES SOFT 25 0.0034
137 PULMONARY PAIN 10 0.0034
138 BOWEL MOVEMENT IRREGULARITY 26 0.0034
139 ILEUS 42 0.0034
140 COLORECTAL CANCER METASTATIC 8 0.0034
141 DRUG USE DISORDER 28 0.0033
142 LARGE INTESTINAL ULCER 9 0.0033
143 BLOOD PHOSPHORUS INCREASED 9 0.0033
144 HYPOVOLAEMIA 19 0.0032
145 CHAPPED LIPS 14 0.0032
146 DIVERTICULUM INTESTINAL 14 0.0032
147 HYPERPARATHYROIDISM SECONDARY 8 0.0032
148 IRON DEFICIENCY ANAEMIA 29 0.0031
149 ERYTHEMA NODOSUM 11 0.0031
150 ABDOMINAL INFECTION 8 0.0031
151 DERMATITIS ACNEIFORM 19 0.0031
152 COLITIS ULCERATIVE 137 0.0031
153 DRUG LEVEL ABOVE THERAPEUTIC 14 0.0031
154 ONYCHOCLASIS 21 0.0030
155 THORACIC VERTEBRAL FRACTURE 9 0.0030
156 MUCOUS STOOLS 15 0.0030
157 GASTROINTESTINAL SOUNDS ABNORMAL 15 0.0030
158 OESOPHAGEAL CANDIDIASIS 12 0.0030
159 NEUTROPHIL COUNT DECREASED 122 0.0030
160 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 212 0.0030
161 METASTASES TO SPINE 10 0.0030
162 FRUSTRATION TOLERANCE DECREASED 24 0.0030
163 PARONYCHIA 13 0.0030
164 SKIN LESION 81 0.0029
165 BLOOD CREATININE INCREASED 191 0.0029
166 BRAIN NATRIURETIC PEPTIDE INCREASED 9 0.0029
167 CROHN'S DISEASE 20 0.0029
168 TUMOUR MARKER INCREASED 14 0.0029
169 CONSTIPATION 628 0.0029
170 GASTROENTERITIS 42 0.0029
171 RENAL FAILURE CHRONIC 22 0.0029
172 NASAL POLYPS 14 0.0028
173 DEHYDRATION 379 0.0028
174 TOXIC EPIDERMAL NECROLYSIS 43 0.0028
175 LUNG NEOPLASM 12 0.0028
176 PNEUMATOSIS INTESTINALIS 8 0.0028
177 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 18 0.0028
178 PNEUMONIA ASPIRATION 69 0.0028
179 OESOPHAGITIS 30 0.0027
180 EXOSTOSIS 25 0.0027
181 SARCOIDOSIS 13 0.0027
182 DIARRHOEA 1743 0.0027
183 OBSTRUCTIVE AIRWAYS DISORDER 30 0.0027
184 RESPIRATORY DEPRESSION 33 0.0027
185 BRAIN HERNIATION 8 0.0027
186 BLOOD MAGNESIUM DECREASED 23 0.0027
187 THYROIDITIS 8 0.0027
188 NORMOCHROMIC NORMOCYTIC ANAEMIA 8 0.0027
189 KERATITIS 8 0.0026
190 ANAL FISTULA 14 0.0026
191 ACIDOSIS 20 0.0026
192 BLOOD BILIRUBIN INCREASED 70 0.0026
193 HYPOCALCAEMIA 49 0.0026
194 DRUG EFFECT LESS THAN EXPECTED 38 0.0026
195 BLOOD CREATININE DECREASED 8 0.0026
196 DUODENAL ULCER 18 0.0025
197 INTESTINAL ISCHAEMIA 14 0.0025
198 NEUTROPENIC SEPSIS 18 0.0025
199 DRUG ABUSE 209 0.0025
200 FISTULA 28 0.0025
201 MULTIPLE DRUG OVERDOSE INTENTIONAL 8 0.0025
202 SKIN EROSION 8 0.0025
203 ANGINA UNSTABLE 16 0.0025
204 PNEUMONITIS 67 0.0025
205 INFUSION RELATED REACTION 162 0.0024
206 ANAL FISSURE 13 0.0024
207 FEBRILE NEUTROPENIA 160 0.0024
208 DYSPEPSIA 237 0.0024
209 NEPHRITIS 8 0.0024
210 PERIPHERAL SENSORY NEUROPATHY 14 0.0024
211 GAMMA-GLUTAMYLTRANSFERASE INCREASED 53 0.0024
212 BLOOD ALKALINE PHOSPHATASE INCREASED 59 0.0024
213 BRONCHIECTASIS 16 0.0024
214 INTENTIONAL PRODUCT MISUSE 207 0.0024
215 C-REACTIVE PROTEIN INCREASED 86 0.0024
216 MULTIPLE MYELOMA 11 0.0024
217 ANAEMIA 450 0.0024
218 PANCREATITIS ACUTE 53 0.0024
219 TONGUE DISCOMFORT 10 0.0024
220 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 9 0.0024
221 DEFORMITY 22 0.0024
222 FEBRILE BONE MARROW APLASIA 10 0.0024
223 CLAVICLE FRACTURE 9 0.0023
224 ANAL INCONTINENCE 21 0.0023
225 APHTHOUS ULCER 18 0.0023
226 HYPERREFLEXIA 8 0.0023
227 STOMATITIS 139 0.0023
228 SINUS BRADYCARDIA 22 0.0023
229 BLOOD PRESSURE SYSTOLIC INCREASED 44 0.0023
230 CATHETERISATION CARDIAC 10 0.0023
231 MUCOSAL INFLAMMATION 59 0.0023
232 ERYTHEMA MULTIFORME 21 0.0022
233 ANOREXIA 29 0.0022
234 HAEMORRHAGIC DIATHESIS 8 0.0022
235 MIOSIS 18 0.0022
236 FLANK PAIN 21 0.0022
237 RENAL FAILURE ACUTE 95 0.0022
238 METASTASES TO LYMPH NODES 15 0.0022
239 RENAL TRANSPLANT 8 0.0022
240 TENDERNESS 23 0.0022
241 URINE ABNORMALITY 10 0.0022
242 HYPERURICAEMIA 9 0.0022
243 SELF-MEDICATION 9 0.0022
244 BUNDLE BRANCH BLOCK RIGHT 10 0.0022
245 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 11 0.0022
246 FLATULENCE 123 0.0022
247 GASTROINTESTINAL PERFORATION 9 0.0022
248 INTESTINAL OBSTRUCTION 81 0.0021
249 PNEUMOTHORAX 34 0.0021
250 ORAL PAIN 48 0.0021
251 HEPATIC FUNCTION ABNORMAL 80 0.0021
252 ASCITES 63 0.0021
253 INTESTINAL PERFORATION 24 0.0021
254 DISSEMINATED INTRAVASCULAR COAGULATION 30 0.0021
255 PROTEIN TOTAL DECREASED 8 0.0021
256 PULMONARY THROMBOSIS 23 0.0021
257 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 49 0.0021
258 HAEMODYNAMIC INSTABILITY 16 0.0021
259 OSTEOARTHRITIS 89 0.0021
260 ABDOMINAL PAIN 488 0.0021
261 UNDERDOSE 153 0.0021
262 LEFT VENTRICULAR DYSFUNCTION 14 0.0021
263 NON-SMALL CELL LUNG CANCER 10 0.0021
264 FAECAL INCONTINENCE 10 0.0021
265 CARDIAC MURMUR 18 0.0021
266 RENAL PAIN 22 0.0021
267 CLOSTRIDIUM DIFFICILE COLITIS 22 0.0021
268 ENTEROCOCCAL INFECTION 10 0.0021
269 ANORECTAL DISCOMFORT 11 0.0021
270 SKIN WARM 12 0.0021
271 BLOOD POTASSIUM DECREASED 62 0.0021
272 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 14 0.0021
273 MELANOCYTIC NAEVUS 9 0.0021
274 BLOOD CALCIUM DECREASED 23 0.0020
275 INFLAMMATORY BOWEL DISEASE 20 0.0020
276 ELECTROCARDIOGRAM ABNORMAL 16 0.0020
277 ABDOMINAL ABSCESS 9 0.0020
278 DIARRHOEA HAEMORRHAGIC 19 0.0020
279 BLOOD PRESSURE DIASTOLIC DECREASED 15 0.0020
280 LYMPHOEDEMA 14 0.0020
281 ABDOMINAL TENDERNESS 10 0.0020
282 HUNGER 28 0.0020
283 PROTHROMBIN TIME PROLONGED 12 0.0020
284 OBSTRUCTION 8 0.0020
285 RIGHT VENTRICULAR FAILURE 14 0.0020
286 HYPONATRAEMIA 110 0.0020
287 SKIN FISSURES 38 0.0019
288 NEUTROPENIA 264 0.0019
289 BLOOD IRON DECREASED 23 0.0019
290 RENAL FUNCTION TEST ABNORMAL 9 0.0019
291 BACTERAEMIA 23 0.0019
292 OLIGURIA 12 0.0019
293 THYROID FUNCTION TEST ABNORMAL 8 0.0019
294 CARDIAC ARREST 157 0.0019
295 SENSITIVITY TO WEATHER CHANGE 10 0.0019
296 SCHIZOPHRENIA 23 0.0019
297 ABSCESS LIMB 8 0.0019
298 ORAL DISCOMFORT 26 0.0019
299 ATELECTASIS 18 0.0019
300 DIZZINESS POSTURAL 18 0.0019
301 PAROSMIA 14 0.0019
302 WHEEZING 110 0.0019
303 BLOOD UREA INCREASED 31 0.0018
304 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 19 0.0018
305 HAEMORRHOIDS 36 0.0018
306 DECUBITUS ULCER 15 0.0018
307 PLEURAL EFFUSION 112 0.0018
308 BLOOD LACTATE DEHYDROGENASE INCREASED 29 0.0018
309 ASPIRATION 20 0.0018
310 DECREASED APPETITE 422 0.0018
311 FLUID INTAKE REDUCED 9 0.0018
312 AFFECTIVE DISORDER 14 0.0018
313 COLITIS ISCHAEMIC 12 0.0018
314 DYSPHORIA 9 0.0018
315 SUSPECTED OFF LABEL USE 8 0.0018
316 SENSITIVE SKIN 13 0.0018
317 ATRIAL FLUTTER 14 0.0018
318 WEIGHT DECREASED 489 0.0017
319 NEPHROTIC SYNDROME 12 0.0017
320 WHITE BLOOD CELL COUNT DECREASED 189 0.0017
321 RENAL IMPAIRMENT 146 0.0017
322 NEPHROGENIC ANAEMIA 8 0.0017
323 HYPERTHYROIDISM 25 0.0017
324 MALABSORPTION 9 0.0017
325 COMA 82 0.0017
326 METABOLIC ACIDOSIS 55 0.0017
327 URINE OUTPUT DECREASED 15 0.0017
328 C-REACTIVE PROTEIN ABNORMAL 11 0.0017
329 DEFAECATION URGENCY 12 0.0017
330 PYREXIA 591 0.0017
331 METASTASES TO LIVER 30 0.0017
332 TUMOUR LYSIS SYNDROME 15 0.0017
333 LUNG INFILTRATION 15 0.0017
334 TOXIC SKIN ERUPTION 17 0.0017
335 GASTROINTESTINAL MOTILITY DISORDER 9 0.0017
336 LOWER RESPIRATORY TRACT INFECTION 76 0.0017
337 PRODUCT RESIDUE PRESENT 9 0.0017
338 HYPOTHYROIDISM 53 0.0017
339 PRODUCT ADMINISTRATION INTERRUPTED 13 0.0017
340 PLATELET COUNT DECREASED 176 0.0016
341 URINARY RETENTION 55 0.0016
342 PRESYNCOPE 40 0.0016
343 BLOOD SODIUM DECREASED 31 0.0016
344 METASTASES TO LUNG 19 0.0016
345 SEPSIS 183 0.0016
346 BLOOD ALBUMIN DECREASED 13 0.0016
347 MYDRIASIS 21 0.0016
348 PNEUMONIA BACTERIAL 15 0.0016
349 CHOKING SENSATION 9 0.0016
350 SEPTIC SHOCK 71 0.0016
351 ALANINE AMINOTRANSFERASE INCREASED 100 0.0016
352 TASTE DISORDER 33 0.0016
353 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 293 0.0016
354 PRODUCT TASTE ABNORMAL 22 0.0016
355 ABDOMINAL DISTENSION 169 0.0016
356 FEELING COLD 45 0.0016
357 BACTERIAL INFECTION 30 0.0016
358 DRY EYE 80 0.0016
359 SPINAL OSTEOARTHRITIS 14 0.0016
360 HYPERLIPIDAEMIA 19 0.0016
361 INFUSION SITE SWELLING 10 0.0016
362 CHOLECYSTITIS ACUTE 9 0.0016
363 BREAST CANCER METASTATIC 17 0.0016
364 LEUKOPENIA 79 0.0016
365 TOXIC ENCEPHALOPATHY 8 0.0016
366 TROPONIN INCREASED 12 0.0016
367 DRUG LEVEL INCREASED 26 0.0016
368 HAEMATOCRIT DECREASED 31 0.0016
369 PULMONARY TOXICITY 11 0.0016
370 PERIPHERAL VASCULAR DISORDER 8 0.0016
371 CONTRAINDICATED PRODUCT ADMINISTERED 47 0.0016
372 GASTROINTESTINAL DISORDER 139 0.0016
373 CHROMATURIA 35 0.0015
374 LIVER FUNCTION TEST ABNORMAL 45 0.0015
375 ASPARTATE AMINOTRANSFERASE INCREASED 82 0.0015
376 PERIORBITAL OEDEMA 8 0.0015
377 HEPATITIS ACUTE 10 0.0015
378 VITAMIN D DEFICIENCY 15 0.0015
379 RENAL TUBULAR NECROSIS 15 0.0015
380 BLOOD LACTIC ACID INCREASED 8 0.0015
381 SUDDEN DEATH 16 0.0015
382 THROMBOCYTOPENIA 169 0.0015
383 HAEMATEMESIS 38 0.0015
384 BRAIN INJURY 15 0.0015
385 CHOLELITHIASIS 49 0.0015
386 SQUAMOUS CELL CARCINOMA OF SKIN 9 0.0015
387 INTERSTITIAL LUNG DISEASE 72 0.0015
388 DRUG LEVEL DECREASED 15 0.0015
389 GASTRIC ULCER 28 0.0015
390 CARDIOGENIC SHOCK 21 0.0015
391 HICCUPS 12 0.0015
392 POST PROCEDURAL COMPLICATION 28 0.0015
393 HYPERKALAEMIA 51 0.0015
394 PANCYTOPENIA 81 0.0014
395 PRODUCTIVE COUGH 69 0.0014
396 OVERDOSE 310 0.0014
397 LIPASE INCREASED 11 0.0014
398 MALIGNANT NEOPLASM PROGRESSION 147 0.0014
399 WEIGHT FLUCTUATION 15 0.0014
400 SKIN ULCER 37 0.0014
401 DEVICE RELATED INFECTION 22 0.0014
402 ENCEPHALOPATHY 35 0.0014
403 POLYNEUROPATHY 17 0.0014
404 HOSPICE CARE 14 0.0014
405 CONJUNCTIVITIS 26 0.0014
406 THIRST 25 0.0014
407 MULTI-ORGAN FAILURE 24 0.0014
408 MUSCLE STRAIN 12 0.0014
409 MOUTH ULCERATION 29 0.0014
410 POISONING DELIBERATE 13 0.0014
411 PRODUCT PACKAGING ISSUE 13 0.0014
412 SPLENOMEGALY 16 0.0014
413 SLEEP DISORDER 96 0.0014
414 HEPATIC FAILURE 41 0.0014
415 BLOOD TRIGLYCERIDES INCREASED 24 0.0014
416 LIMB DISCOMFORT 42 0.0014
417 ENERGY INCREASED 8 0.0014
418 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
419 BLOOD TEST ABNORMAL 19 0.0014
420 ISCHAEMIC STROKE 24 0.0013
421 EPILEPSY 41 0.0013
422 FULL BLOOD COUNT DECREASED 27 0.0013
423 ACCIDENTAL OVERDOSE 49 0.0013
424 GASTROINTESTINAL INFECTION 12 0.0013
425 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 95 0.0013
426 POSTOPERATIVE WOUND INFECTION 9 0.0013
427 HAEMOGLOBIN DECREASED 136 0.0013
428 DRUG TOXICITY 18 0.0013
429 HIATUS HERNIA 17 0.0013
430 HAEMODIALYSIS 11 0.0013
431 INTENTIONAL OVERDOSE 84 0.0013
432 LIVER DISORDER 58 0.0013
433 PLATELET COUNT INCREASED 17 0.0013
434 PERITONITIS 27 0.0013
435 HEPATOTOXICITY 29 0.0013
436 UROSEPSIS 12 0.0013
437 GENERALISED OEDEMA 16 0.0013
438 ANGINA PECTORIS 37 0.0013
439 HYPOPHAGIA 33 0.0013
440 PANCREATITIS 68 0.0013
441 LETHARGY 74 0.0013
442 PSEUDOMONAS INFECTION 11 0.0013
443 ADVERSE REACTION 17 0.0013
444 LYMPHOPENIA 18 0.0013
445 BRAIN OEDEMA 16 0.0013
446 NEUROLEPTIC MALIGNANT SYNDROME 15 0.0013
447 RIB FRACTURE 26 0.0013
448 OEDEMA PERIPHERAL 154 0.0013
449 PROTEINURIA 24 0.0013
450 MENTAL STATUS CHANGES 35 0.0013
451 IRRITABLE BOWEL SYNDROME 27 0.0013
452 CHOLECYSTITIS 15 0.0013
453 HAEMATURIA 43 0.0013
454 GASTROOESOPHAGEAL REFLUX DISEASE 101 0.0013
455 SCIATICA 20 0.0013
456 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
457 NEUROPATHY PERIPHERAL 119 0.0012
458 DRUG INTERACTION 198 0.0012
459 PURPURA 11 0.0012
460 METASTASES TO CENTRAL NERVOUS SYSTEM 16 0.0012
461 VOMITING 579 0.0012
462 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 36 0.0012
463 NAUSEA 971 0.0012
464 MELAENA 27 0.0012
465 LUNG INFECTION 19 0.0012
466 RETCHING 26 0.0012
467 BODY TEMPERATURE DECREASED 12 0.0012
468 COORDINATION ABNORMAL 17 0.0012
469 OROPHARYNGEAL DISCOMFORT 11 0.0012
470 SPINAL COMPRESSION FRACTURE 10 0.0012
471 ARTERIOSCLEROSIS CORONARY ARTERY 8 0.0012
472 PULMONARY OEDEMA 54 0.0012
473 ABDOMINAL PAIN UPPER 248 0.0012
474 PNEUMONIA 389 0.0012
475 CARDIAC FAILURE ACUTE 8 0.0012
476 ALTERED STATE OF CONSCIOUSNESS 26 0.0012
477 WHITE BLOOD CELL COUNT INCREASED 46 0.0012
478 DYSPNOEA EXERTIONAL 45 0.0012
479 POST-TRAUMATIC STRESS DISORDER 8 0.0012
480 INTERNATIONAL NORMALISED RATIO INCREASED 34 0.0012
481 TOXICITY TO VARIOUS AGENTS 201 0.0012
482 DEPRESSED MOOD 63 0.0012
483 GRAND MAL CONVULSION 11 0.0012
484 LYMPHOCYTE COUNT DECREASED 21 0.0012
485 FEEDING DISORDER 24 0.0012
486 OROPHARYNGEAL PAIN 109 0.0012
487 CIRCULATORY COLLAPSE 20 0.0012
488 MYOCLONUS 14 0.0012
489 OFF LABEL USE 1027 0.0012
490 SYNCOPE 117 0.0012
491 UPPER RESPIRATORY TRACT INFECTION 54 0.0012
492 ANURIA 10 0.0012
493 TACHYCARDIA 103 0.0012
494 NEPHROPATHY TOXIC 13 0.0012
495 OXYGEN SATURATION DECREASED 65 0.0012
496 HAIR GROWTH ABNORMAL 8 0.0012
497 LARGE INTESTINE POLYP 8 0.0012
498 PYELONEPHRITIS 10 0.0012
499 ADRENAL INSUFFICIENCY 14 0.0012
500 ORTHOSTATIC HYPOTENSION 20 0.0011
501 EXTRASYSTOLES 8 0.0011
502 NAIL DISORDER 10 0.0011
503 INFECTION 165 0.0011
504 CARDIOMEGALY 14 0.0011
505 JOINT DISLOCATION 12 0.0011
506 HEPATITIS 29 0.0011
507 RENAL CYST 9 0.0011
508 EAR PAIN 22 0.0011
509 UPPER GASTROINTESTINAL HAEMORRHAGE 19 0.0011
510 DIVERTICULUM 8 0.0011
511 PERICARDIAL EFFUSION 26 0.0011
512 RASH MACULO-PAPULAR 25 0.0011
513 UNRESPONSIVE TO STIMULI 29 0.0011
514 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 19 0.0011
515 ACUTE KIDNEY INJURY 171 0.0011
516 GRAFT VERSUS HOST DISEASE 8 0.0011
517 DEPRESSED LEVEL OF CONSCIOUSNESS 44 0.0011
518 OEDEMA 60 0.0011
519 SHOCK HAEMORRHAGIC 9 0.0011
520 DERMATITIS BULLOUS 8 0.0011
521 PULMONARY ARTERIAL HYPERTENSION 16 0.0011
522 GASTRITIS 29 0.0011
523 INCREASED APPETITE 21 0.0011
524 RHINORRHOEA 71 0.0011
525 BRADYCARDIA 58 0.0011
526 PHOTOSENSITIVITY REACTION 18 0.0011
527 RETINAL DETACHMENT 10 0.0011
528 ACUTE CORONARY SYNDROME 9 0.0011
529 HYPOTHERMIA 11 0.0011
530 EMBOLISM 9 0.0011
531 LOWER GASTROINTESTINAL HAEMORRHAGE 8 0.0011
532 HYPOXIA 38 0.0011
533 JAUNDICE 29 0.0011
534 ARRHYTHMIA 51 0.0011
535 HEPATIC ENCEPHALOPATHY 10 0.0011
536 NOCTURIA 13 0.0011
537 HYPERGLYCAEMIA 39 0.0011
538 HYDRONEPHROSIS 8 0.0011
539 ABDOMINAL PAIN LOWER 27 0.0011
540 CYSTITIS 34 0.0011
541 DRUG INTOLERANCE 103 0.0011
542 CONFUSIONAL STATE 172 0.0011
543 PEMPHIGOID 8 0.0011
544 DYSURIA 39 0.0011
545 MALAISE 464 0.0011
546 DRUG INEFFECTIVE 1391 0.0011
547 MYOCARDIAL ISCHAEMIA 12 0.0011
548 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 55 0.0011
549 CLOSTRIDIUM DIFFICILE INFECTION 23 0.0011
550 OSTEOMYELITIS 19 0.0010
551 FATIGUE 814 0.0010
552 SHOCK 24 0.0010
553 URINARY TRACT INFECTION 178 0.0010
554 HYPOTENSION 209 0.0010
555 INCONTINENCE 11 0.0010
556 ABDOMINAL DISCOMFORT 174 0.0010
557 HAEMOLYSIS 8 0.0010
558 PRESCRIBED OVERDOSE 20 0.0010
559 TENDONITIS 16 0.0010
560 HERPES ZOSTER 59 0.0010
561 INCORRECT DOSE ADMINISTERED 234 0.0010
562 MOBILITY DECREASED 73 0.0010
563 DELIRIUM 35 0.0010
564 BONE PAIN 59 0.0010
565 COLON CANCER 15 0.0010
566 GOUT 18 0.0010
567 ASTHENIA 377 0.0010
568 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 55 0.0010
569 PNEUMOCYSTIS JIROVECII PNEUMONIA 10 0.0010
570 STEVENS-JOHNSON SYNDROME 22 0.0010
571 MOTOR DYSFUNCTION 10 0.0010
572 CHILLS 115 0.0010
573 RED BLOOD CELL COUNT DECREASED 28 0.0010
574 DISEASE PROGRESSION 115 0.0010
575 GENERAL PHYSICAL HEALTH DETERIORATION 112 0.0010
576 RENAL FAILURE 128 0.0010
577 VENTRICULAR EXTRASYSTOLES 10 0.0010
578 NIGHT SWEATS 31 0.0010
579 BLOOD PRESSURE FLUCTUATION 23 0.0010
580 BRAIN FOG 15 0.0010
581 TACHYPNOEA 13 0.0010
582 DERMATITIS ALLERGIC 12 0.0010
583 FULL BLOOD COUNT ABNORMAL 10 0.0009
584 HEMIPARESIS 16 0.0009
585 PERIPHERAL SWELLING 145 0.0009
586 ABSCESS 15 0.0009
587 SOMNOLENCE 189 0.0009
588 RHABDOMYOLYSIS 39 0.0009
589 CARDIAC FAILURE 75 0.0009
590 ERYTHEMA 192 0.0009
591 DISORIENTATION 37 0.0009
592 BODY TEMPERATURE INCREASED 19 0.0009
593 ATAXIA 11 0.0009
594 LACTIC ACIDOSIS 30 0.0009
595 NEOPLASM PROGRESSION 32 0.0009
596 BLOOD PRESSURE DECREASED 61 0.0009
597 HEPATOMEGALY 9 0.0009
598 INFLUENZA 102 0.0009
599 METASTASES TO BONE 15 0.0009
600 ATRIAL FIBRILLATION 89 0.0009
601 THROAT IRRITATION 41 0.0009
602 ANHEDONIA 24 0.0009
603 MUSCULOSKELETAL STIFFNESS 80 0.0009
604 DEEP VEIN THROMBOSIS 59 0.0009
605 ACUTE RESPIRATORY DISTRESS SYNDROME 16 0.0009
606 PHOTOPHOBIA 17 0.0009
607 DIVERTICULITIS 25 0.0009
608 RENAL DISORDER 42 0.0009
609 EJECTION FRACTION DECREASED 14 0.0009
610 CYTOPENIA 11 0.0009
611 CYTOKINE RELEASE SYNDROME 18 0.0009
612 HYPERTENSION 190 0.0009
613 GALLBLADDER DISORDER 16 0.0009
614 QUALITY OF LIFE DECREASED 12 0.0009
615 THERAPEUTIC PRODUCT EFFECT DECREASED 40 0.0009
616 INTENTIONAL SELF-INJURY 18 0.0009
617 BONE MARROW FAILURE 18 0.0009
618 CHOLESTASIS 17 0.0009
619 HEART RATE IRREGULAR 20 0.0009
620 DISCOMFORT 54 0.0009
621 HAIR COLOUR CHANGES 11 0.0009
622 ACUTE RESPIRATORY FAILURE 17 0.0009
623 RESPIRATORY TRACT INFECTION 23 0.0009
624 POOR QUALITY SLEEP 19 0.0009
625 PAIN IN JAW 25 0.0009
626 LIP DRY 8 0.0009
627 PULMONARY EMBOLISM 83 0.0009
628 DYSPHONIA 51 0.0009
629 MUSCLE ATROPHY 11 0.0009
630 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
631 PULMONARY HYPERTENSION 18 0.0009
632 PETECHIAE 9 0.0009
633 AGRANULOCYTOSIS 16 0.0009
634 HEPATIC STEATOSIS 16 0.0009
635 TRANSFUSION 9 0.0009
636 VASCULITIS 10 0.0009
637 SEIZURE 99 0.0009
638 INJECTION SITE DISCOMFORT 9 0.0009
639 PAIN OF SKIN 23 0.0009
640 DYSPNOEA 482 0.0009
641 SEASONAL ALLERGY 12 0.0008
642 MULTIPLE ORGAN DYSFUNCTION SYNDROME 24 0.0008
643 SNEEZING 19 0.0008
644 ARTHROPATHY 47 0.0008
645 AGEUSIA 21 0.0008
646 BLOOD CHOLESTEROL INCREASED 39 0.0008
647 MUSCLE RIGIDITY 10 0.0008
648 DECREASED ACTIVITY 9 0.0008
649 BALANCE DISORDER 72 0.0008
650 TREATMENT FAILURE 69 0.0008
651 DYSPHAGIA 79 0.0008
652 CONTUSION 80 0.0008
653 FACE OEDEMA 14 0.0008
654 APHASIA 25 0.0008
655 MENTAL DISORDER 36 0.0008
656 PRODUCT USE COMPLAINT 13 0.0008
657 NERVOUSNESS 43 0.0008
658 RESPIRATORY FAILURE 60 0.0008
659 SPEECH DISORDER 43 0.0008
660 PLASMA CELL MYELOMA 32 0.0008
661 BLISTER 46 0.0008
662 ANAPHYLACTIC REACTION 45 0.0008
663 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 39 0.0008
664 HYPOAESTHESIA 121 0.0008
665 COUGH 226 0.0008
666 THINKING ABNORMAL 15 0.0008
667 ACUTE HEPATIC FAILURE 11 0.0008
668 LOSS OF CONSCIOUSNESS 103 0.0008
669 HAEMORRHAGE INTRACRANIAL 12 0.0008
670 GASTROINTESTINAL HAEMORRHAGE 67 0.0008
671 EATING DISORDER 17 0.0008
672 STATUS EPILEPTICUS 9 0.0008
673 MUSCLE SPASMS 146 0.0008
674 HEPATIC ENZYME INCREASED 54 0.0008
675 ECONOMIC PROBLEM 12 0.0008
676 DRUG ERUPTION 14 0.0008
677 DERMATITIS CONTACT 9 0.0008
678 HAEMOPTYSIS 22 0.0008
679 FALL 262 0.0008
680 TOOTH ABSCESS 8 0.0008
681 CHEST PAIN 145 0.0008
682 CYTOMEGALOVIRUS INFECTION 13 0.0008
683 DRUG EFFECT DECREASED 42 0.0008
684 EAR DISCOMFORT 8 0.0008
685 GLAUCOMA 15 0.0008
686 MYELOSUPPRESSION 28 0.0008
687 INFUSION SITE PAIN 10 0.0008
688 SINUS TACHYCARDIA 11 0.0008
689 CELLULITIS 39 0.0008
690 LIMB INJURY 21 0.0008
691 CATARACT 46 0.0008
692 HYPERBILIRUBINAEMIA 8 0.0008
693 JOINT SWELLING 93 0.0008
694 HOT FLUSH 58 0.0008
695 POLLAKIURIA 32 0.0008
696 TOOTH DISORDER 17 0.0008
697 CYANOSIS 12 0.0008
698 FOLLICULITIS 8 0.0008
699 WITHDRAWAL SYNDROME 32 0.0008
700 CORONARY ARTERY DISEASE 23 0.0008
701 POOR QUALITY PRODUCT ADMINISTERED 8 0.0008
702 ULCER 12 0.0008
703 APATHY 11 0.0008
704 PAIN IN EXTREMITY 221 0.0007
705 SKIN DISORDER 25 0.0007
706 NASAL CONGESTION 44 0.0007
707 EPISTAXIS 56 0.0007
708 HEART RATE INCREASED 74 0.0007
709 MALIGNANT MELANOMA 10 0.0007
710 JOINT RANGE OF MOTION DECREASED 10 0.0007
711 URINARY INCONTINENCE 22 0.0007
712 PRODUCT ADMINISTRATION ERROR 15 0.0007
713 GAIT DISTURBANCE 142 0.0007
714 FIBROMYALGIA 18 0.0007
715 SINUS CONGESTION 10 0.0007
716 IMMUNODEFICIENCY 11 0.0007
717 ARTHRITIS 58 0.0007
718 UVEITIS 10 0.0007
719 HEADACHE 462 0.0007
720 BACK PAIN 171 0.0007
721 LIVER INJURY 18 0.0007
722 PAIN 448 0.0007
723 RESPIRATORY ARREST 20 0.0007
724 GENERALISED TONIC-CLONIC SEIZURE 12 0.0007
725 HERNIA 14 0.0007
726 HYPOGLYCAEMIA 35 0.0007
727 SYNOVITIS 13 0.0007
728 INFLAMMATION 37 0.0007
729 DRY MOUTH 58 0.0007
730 DRY SKIN 95 0.0007
731 DEVICE OCCLUSION 10 0.0007
732 HOSPITALISATION 109 0.0007
733 ARTHRALGIA 293 0.0007
734 SWOLLEN TONGUE 22 0.0007
735 DRUG-INDUCED LIVER INJURY 22 0.0007
736 IMPAIRED QUALITY OF LIFE 10 0.0007
737 LUNG DISORDER 34 0.0007
738 DIPLOPIA 18 0.0007
739 NASOPHARYNGITIS 127 0.0007
740 POST PROCEDURAL HAEMORRHAGE 8 0.0007
741 SENSORY DISTURBANCE 11 0.0007
742 COVID-19 120 0.0007
743 CHEST DISCOMFORT 70 0.0007
744 HEART RATE DECREASED 24 0.0007
745 PULMONARY CONGESTION 9 0.0007
746 SARS-COV-2 TEST POSITIVE 9 0.0007
747 ACUTE MYOCARDIAL INFARCTION 20 0.0007
748 TRANSAMINASES INCREASED 15 0.0007
749 DYSGEUSIA 50 0.0007
750 VERTIGO 41 0.0007
751 INSOMNIA 179 0.0007
752 DIZZINESS 335 0.0007
753 PULMONARY MASS 10 0.0007
754 IMPAIRED HEALING 22 0.0007
755 GLOSSODYNIA 15 0.0007
756 CHOKING 13 0.0007
757 RASH PRURITIC 36 0.0007
758 LEUKOCYTOSIS 12 0.0007
759 TOOTHACHE 12 0.0007
760 HYPERSOMNIA 19 0.0007
761 CONDITION AGGRAVATED 201 0.0007
762 RESTLESS LEGS SYNDROME 12 0.0007
763 SUICIDE ATTEMPT 40 0.0007
764 RASH MACULAR 23 0.0007
765 CORONARY ARTERY OCCLUSION 9 0.0007
766 NO THERAPEUTIC RESPONSE 8 0.0007
767 PERIPHERAL COLDNESS 9 0.0007
768 JOINT INJURY 14 0.0007
769 NEPHROLITHIASIS 30 0.0007
770 INSURANCE ISSUE 10 0.0007
771 TRANSIENT ISCHAEMIC ATTACK 22 0.0007
772 CANDIDA INFECTION 11 0.0007
773 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
774 SKIN CANCER 14 0.0006
775 INJECTION SITE EXTRAVASATION 8 0.0006
776 HYPERCALCAEMIA 8 0.0006
777 MUSCULAR WEAKNESS 73 0.0006
778 THERAPY PARTIAL RESPONDER 10 0.0006
779 HEPATIC CIRRHOSIS 12 0.0006
780 DIALYSIS 9 0.0006
781 ALOPECIA 124 0.0006
782 CONVULSION 36 0.0006
783 RASH 274 0.0006
784 BLOOD PRESSURE INCREASED 96 0.0006
785 EOSINOPHILIA 11 0.0006
786 HYPERSENSITIVITY 116 0.0006
787 MOVEMENT DISORDER 20 0.0006
788 CARDIO-RESPIRATORY ARREST 26 0.0006
789 TREATMENT NONCOMPLIANCE 34 0.0006
790 HYPOKINESIA 9 0.0006
791 HAEMATOMA 16 0.0006
792 PARAESTHESIA 97 0.0006
793 RESPIRATORY DISTRESS 17 0.0006
794 AGITATION 45 0.0006
795 WEIGHT INCREASED 137 0.0006
796 MYALGIA 104 0.0006
797 KIDNEY INFECTION 12 0.0006
798 CARDIOMYOPATHY 9 0.0006
799 OSTEONECROSIS 20 0.0006
800 TREMOR 101 0.0006
801 NECK PAIN 34 0.0006
802 BRONCHITIS 45 0.0006
803 OSTEOPOROSIS 25 0.0006
804 PALPITATIONS 71 0.0006
805 LIVER FUNCTION TEST INCREASED 13 0.0006
806 UPPER LIMB FRACTURE 12 0.0006
807 PRESCRIBED UNDERDOSE 12 0.0006
808 RESTLESSNESS 22 0.0006
809 PRODUCT DOSE OMISSION IN ERROR 17 0.0006
810 HALLUCINATION 45 0.0006
811 HYPOAESTHESIA ORAL 9 0.0006
812 PERICARDITIS 10 0.0006
813 ASTHMA 67 0.0006
814 SKIN EXFOLIATION 50 0.0006
815 PALLOR 16 0.0006
816 RASH ERYTHEMATOUS 28 0.0006
817 DYSARTHRIA 22 0.0006
818 DYSSTASIA 17 0.0006
819 MUSCULOSKELETAL DISCOMFORT 10 0.0006
820 ACUTE MYELOID LEUKAEMIA 9 0.0006
821 SWELLING 54 0.0006
822 SLEEP APNOEA SYNDROME 11 0.0006
823 PSYCHOTIC DISORDER 17 0.0006
824 ROAD TRAFFIC ACCIDENT 24 0.0006
825 PULMONARY FIBROSIS 11 0.0006
826 CEREBRAL INFARCTION 14 0.0006
827 LIP SWELLING 19 0.0006
828 FLUID RETENTION 29 0.0006
829 HEAD INJURY 18 0.0006
830 ERUCTATION 11 0.0006
831 COLD SWEAT 10 0.0006
832 IRRITABILITY 34 0.0006
833 TYPE 2 DIABETES MELLITUS 19 0.0006
834 MEMORY IMPAIRMENT 76 0.0006
835 CARDIOVASCULAR DISORDER 14 0.0006
836 PRODUCT PRESCRIBING ISSUE 12 0.0006
837 PELVIC PAIN 10 0.0005
838 PANIC ATTACK 20 0.0005
839 END STAGE RENAL DISEASE 10 0.0005
840 STAPHYLOCOCCAL INFECTION 18 0.0005
841 LABORATORY TEST ABNORMAL 16 0.0005
842 DYSKINESIA 22 0.0005
843 COAGULOPATHY 9 0.0005
844 URTICARIA 90 0.0005
845 DEAFNESS 14 0.0005
846 ANGER 18 0.0005
847 CEREBRAL HAEMORRHAGE 19 0.0005
848 ANXIETY 151 0.0005
849 FOOT FRACTURE 10 0.0005
850 EAR INFECTION 14 0.0005
851 DRUG EFFECT INCOMPLETE 19 0.0005
852 RHEUMATOID ARTHRITIS 59 0.0005
853 BASAL CELL CARCINOMA 8 0.0005
854 INJURY 36 0.0005
855 VIRAL INFECTION 17 0.0005
856 LYMPHADENOPATHY 18 0.0005
857 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
858 PRODUCT USE IN UNAPPROVED INDICATION 125 0.0005
859 PRODUCT PRESCRIBING ERROR 12 0.0005
860 PRODUCT DOSE OMISSION ISSUE 148 0.0005
861 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
862 VISION BLURRED 69 0.0005
863 DEMENTIA 14 0.0005
864 SPINAL FRACTURE 10 0.0005
865 LACRIMATION INCREASED 15 0.0005
866 CEREBROVASCULAR ACCIDENT 84 0.0005
867 MENTAL IMPAIRMENT 12 0.0005
868 VISUAL IMPAIRMENT 61 0.0005
869 DEPRESSION 111 0.0005
870 ABASIA 12 0.0005
871 CARDIAC FAILURE CONGESTIVE 39 0.0005
872 NEOPLASM MALIGNANT 32 0.0005
873 DERMATITIS 10 0.0005
874 HYPERHIDROSIS 61 0.0005
875 ABNORMAL DREAMS 13 0.0005
876 SCAR 8 0.0005
877 THERAPY NON-RESPONDER 21 0.0005
878 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
879 DISTURBANCE IN ATTENTION 25 0.0005
880 LUNG NEOPLASM MALIGNANT 19 0.0005
881 AMNESIA 30 0.0005
882 SWELLING FACE 30 0.0005
883 CHRONIC KIDNEY DISEASE 35 0.0005
884 AGGRESSION 23 0.0005
885 FEELING ABNORMAL 110 0.0005
886 MYOCARDIAL INFARCTION 80 0.0005
887 MUSCULOSKELETAL PAIN 24 0.0005
888 SKIN DISCOLOURATION 21 0.0005
889 NEUROTOXICITY 8 0.0005
890 ABNORMAL BEHAVIOUR 18 0.0005
891 EMOTIONAL DISORDER 14 0.0005
892 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
893 COGNITIVE DISORDER 21 0.0004
894 THROMBOSIS 36 0.0004
895 ILLNESS 46 0.0004
896 GASTROENTERITIS VIRAL 8 0.0004
897 FLUSHING 45 0.0004
898 FEELING HOT 27 0.0004
899 PRODUCT USE ISSUE 82 0.0004
900 HIP FRACTURE 14 0.0004
901 BLOOD GLUCOSE ABNORMAL 8 0.0004
902 ANAPHYLACTIC SHOCK 11 0.0004
903 DEATH 365 0.0004
904 ADVERSE DRUG REACTION 38 0.0004
905 FRACTURE 8 0.0004
906 PRURITUS 162 0.0004
907 BLOOD URINE PRESENT 8 0.0004
908 FUNGAL INFECTION 14 0.0004
909 FEELING JITTERY 8 0.0004
910 BURNING SENSATION 29 0.0004
911 INFLUENZA LIKE ILLNESS 34 0.0004
912 NEURALGIA 10 0.0004
913 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 83 0.0004
914 MOOD SWINGS 13 0.0004
915 THROAT TIGHTNESS 11 0.0004
916 OSTEONECROSIS OF JAW 10 0.0004
917 RASH PAPULAR 9 0.0004
918 RESPIRATORY DISORDER 12 0.0004
919 PRODUCT PHYSICAL ISSUE 8 0.0004
920 CARDIAC DISORDER 37 0.0004
921 PRODUCT AVAILABILITY ISSUE 9 0.0004
922 DIABETES MELLITUS 30 0.0004
923 WOUND 11 0.0004
924 MUSCLE TWITCHING 9 0.0004
925 EYE PRURITUS 13 0.0004
926 TOOTH LOSS 8 0.0004
927 ADVERSE EVENT 35 0.0004
928 DRUG WITHDRAWAL SYNDROME 33 0.0004
929 LOCALISED INFECTION 9 0.0004
930 COMPLETED SUICIDE 31 0.0004
931 SINUSITIS 38 0.0004
932 TINNITUS 17 0.0004
933 MOOD ALTERED 10 0.0004
934 MIGRAINE 35 0.0004
935 ECZEMA 19 0.0004
936 MEDICATION ERROR 19 0.0003
937 BLOOD GLUCOSE INCREASED 64 0.0003
938 RENAL INJURY 10 0.0003
939 CRYING 12 0.0003
940 HAEMORRHAGE 34 0.0003
941 ABORTION SPONTANEOUS 13 0.0003
942 BONE DENSITY DECREASED 10 0.0003
943 GLYCOSYLATED HAEMOGLOBIN INCREASED 8 0.0003
944 NO ADVERSE EVENT 57 0.0003
945 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
946 RASH GENERALISED 8 0.0003
947 SURGERY 18 0.0003
948 JOINT STIFFNESS 8 0.0003
949 UNEVALUABLE EVENT 23 0.0003
950 VISUAL ACUITY REDUCED 10 0.0003
951 EYE SWELLING 11 0.0003
952 GASTRIC DISORDER 10 0.0003
953 ACNE 22 0.0003
954 SUICIDAL IDEATION 26 0.0003
955 TARDIVE DYSKINESIA 8 0.0003
956 EMOTIONAL DISTRESS 34 0.0003
957 INTENTIONAL DOSE OMISSION 8 0.0003
958 PRODUCT DOSE OMISSION 18 0.0003
959 OCULAR HYPERAEMIA 13 0.0003
960 ANGIOEDEMA 12 0.0003
961 GAIT INABILITY 9 0.0003
962 FEMUR FRACTURE 8 0.0003
963 NERVOUS SYSTEM DISORDER 8 0.0003
964 BLOOD GLUCOSE DECREASED 12 0.0002
965 EXTRA DOSE ADMINISTERED 10 0.0002
966 BLINDNESS 10 0.0002
967 SKIN IRRITATION 11 0.0002
968 THERAPY INTERRUPTED 17 0.0002
969 HYPOACUSIS 10 0.0002
970 THERAPEUTIC RESPONSE DECREASED 14 0.0002
971 EYE PAIN 13 0.0002
972 EYE IRRITATION 13 0.0002
973 PSORIASIS 29 0.0002
974 DISEASE RECURRENCE 10 0.0002
975 DRUG DEPENDENCE 33 0.0002
976 EXPOSURE DURING PREGNANCY 12 0.0002
977 MULTIPLE SCLEROSIS RELAPSE 12 0.0002
978 COLORECTAL CANCER 8 0.0002
979 INJECTION SITE PAIN 51 0.0002
980 DEPENDENCE 9 0.0002
981 INJECTION SITE BRUISING 12 0.0002
982 INJECTION SITE PRURITUS 10 0.0001
983 PRODUCT STORAGE ERROR 13 0.0001
984 INJECTION SITE SWELLING 11 0.0001
985 INJECTION SITE ERYTHEMA 17 0.0001
986 PROSTATE CANCER 11 0.0001
987 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
988 INJECTION SITE REACTION 9 0.0001
989 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
990 DEVICE ISSUE 11 0.0001
991 BREAST CANCER 11 0.0001
992 INJECTION SITE HAEMORRHAGE 8 0.0001
993 DRUG DOSE OMISSION 14 0.0001
994 PRODUCT QUALITY ISSUE 8 0.0001